RNAZ · Transcode Therapeutics, Inc. · Documents
$1.70
+0.00 (+0.00%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$28.78M
Shares
16.93M
Volume · Oct 19
29.32K
Avg daily vol (3M)
53.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-11-14 | — | |
| 10-Q | — | 2022-11-14 | 2022-09-30 | |
| 8-K | — | 2022-08-15 | — | |
| 10-Q | — | 2022-08-15 | 2022-06-30 | |
| 8-K | — | 2022-08-03 | 2022-07-29 | |
| 8-K | — | 2022-06-23 | 2022-06-22 | |
| 8-K | — | 2022-05-16 | — | |
| 10-Q | — | 2022-05-16 | 2022-03-31 | |
| DEF 14A | — | 2022-05-02 | 2022-06-22 | |
| DEFA14A | — | 2022-05-02 | — | |
| 8-K | — | 2022-04-01 | 2022-03-31 | |
| 10-K | — | 2022-03-31 | 2021-12-31 | |
| 8-K | — | 2021-11-15 | — | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 8-K | — | 2021-09-30 | — | |
| 8-K | — | 2021-08-23 | — | |
| 10-Q | — | 2021-08-23 | 2021-06-30 | |
| 8-K | — | 2021-07-13 | — | |
| S-1/A | — | 2021-06-02 | — | |
| S-1/A | — | 2021-05-03 | — | |
| S-1/A | — | 2021-04-16 | — | |
| S-1/A | — | 2021-04-08 | — | |
| S-1/A | — | 2021-03-24 | — | |
| S-1 | — | 2021-02-26 | — |
Showing 151–174 of 174 filings